News | Remote Viewing Systems | March 21, 2018

NucleusHealth Presents Cloud Medical Image Management Platform-as-a-Service at HIMSS

Nucleus.io delivers a web scale medical imaging and machine learning platform to share images through users’ own tools and specialty workflows

March 21, 2018 — Cloud-based medical image management and teleradiology company NucleusHealth recently announced the commercial licensing of its Platform-as-a-Service (Nucleus PaaS) that was showcased within the Microsoft booth at the Healthcare Information and Management Systems Society (HIMSS) Conference, March 5-9 in Las Vegas. Nucleus PaaS provides integration partners, across every facet of the healthcare industry, with medical imaging data at the speed and scalability of next-generation cloud technology, allowing third parties to deliver medical images through their own tools and specialty workflows.

"Many healthcare systems and companies have either developed or acquired clinical applications to deliver patient data to caregivers while they're remote or mobile," said President and Chief Operating Officer Claude Hooton. "However, the key data missing in these applications are current and prior diagnostic medical images (i.e. DICOM), which are critical for delivering superior patient care, enhancing various workflows, and even for creating new revenue opportunities," said Hooton.

Others in the healthcare industry also have a need to consume medical imaging data in areas such as planning applications for medical devices, for custom manufacturing of implants, for clinical research and tracking of clinical outcomes, and for product development. Nucleus PaaS enables cloud-based medical imaging integration to current clinical systems and to the third-party applications.

By leveraging Microsoft Azure, Nucleus PaaS can empower care teams and unleash new capabilities for the entire imaging ecosystem ranging from providers, medical device manufacturers, pharmaceutical companies and clinical SaaS application developers, to payors. Developers can take full advantage of the platform through a robust layer of RESTful application programming interface (APIs) to support clinical workflows and build custom web-based medical imaging applications much faster and easier. The solution also provides a means to extract greater value from data through advanced analytics and machine learning. Using Nucleus PaaS allows developers to create, test, manage, automate and update their unique apps without having to spend years building their web-based platform.

The Nucleus.io platform powers a complete suite of cloud-based imaging applications built on Nucleus PaaS, each developed to optimize interactions with medical images end-to-end, including diagnostic reading, archiving, image sharing and clinical viewing. Nucleus.io is scalable and enables secure remote access to any internet-enabled device, made possible with patented StatStream technology for immediate access to even the largest of medical images. Nucleus.io's client-side rendering techniques solve for latency with instant load times and a responsive user experience without loss of performance or image quality.

For more information: www.nucleushealth.io

 

Related Content

The U.S. Food and Drug Administration (#FDA) authorized marketing of #Medtronic's #GIGenius, the first device that uses #artificialintelligence (#AI) based on #machinelearning to assist #clinicians in detecting #lesions (such as #polyps or suspected tumors) in the #colon in real time during a c#olonoscopy.

The GI Genius intelligent endoscopy module works in real-time, automatically identifying and marking (with a green box) abnormalities consistent with colorectal polyps, including small flat polyps.

News | Artificial Intelligence | April 12, 2021
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence | April 08, 2021
April 8, 2021 — Varian announced it is collaborating with Google...
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on...
Nano-X Imaging Ltd (Nanox), an innovative medical imaging technology company, announced that its single-source Nanox.ARC digital x-ray technology has received 510(k) clearance from the US Food and Drug Administration.
News | X-Ray | April 02, 2021
April 2, 2021 — Nano-X Imaging Ltd.
Elsevier’s STATdx, a leading radiology diagnostic decision support solution, now includes select Merit-Based Incentive Payment System (MIPS) Measures validated by MDinteractive
News | Clinical Decision Support | April 02, 2021
April 2, 2021 — Elsevier, a global leader in research publishing and information analytics, announced a partnership w
#emphysema #marijuana 2021 ARRS Virtual Annual Meeting research reveals increased rates of emphysema in marijuana smokers, compared to both non-smokers and tobacco-only smokers, as well as greater rates of paraseptal emphysema

Getty Images

News | Lung Imaging | April 02, 2021
April 2, 2021 — A Scientific E-Poster to be presented at the 2021...